Prosaposin: Promoter analysis and central-nervous-system-preferential elements for expression in vivo

Biochemical Journal

Volumn 352, Issue 2, 2000, Pages 549-556

  Sun, Y ^a   Jin, P ^a   Witte, D P ^a   Grabowski, G A ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Luciferase; RORE; Sp1; Transcription; Transgenic mice

Indexed keywords

PROSAPOSIN; RETINOIC ACID RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DNA FLANKING REGION; ENZYME REGULATION; GENE DELETION; GENE EXPRESSION; GENE FUSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; TRANSGENIC MOUSE;

ANIMALS; CENTRAL NERVOUS SYSTEM; GENE EXPRESSION; GLYCOPROTEINS; LUCIFERASES; MICE; MICE, TRANSGENIC; PROMOTER REGIONS (GENETICS); SAPOSINS; TRANSGENES;

ANIMALIA; MUS MUSCULUS;

EID: 0034532731     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/0264-6021:3520549     Document Type: Article

References (32)

1. Saposins: Structure, function, distribution, and molecular genetics
2. Proteolytic processing patterns of prosaposin in insect and mammalian cells
3. Identification of a novel sequence involved in lysosomal sorting of the sphingolipid activator protein prosaposin
4. Sulfatide activator protein. Alternative splicing that generates three mRNAs and a newly found mutalion responsible for a clinical disease
5. Insertion in the mRNA of a metachromatic leukodystrophy patient with sphingolipid activator-1 deficiency
6. Mutation in the sphingolipid activator protein 2 in a patient with a variant of Gaucher disease
7. Mutational analysis in a patient with a variant form of Gaucher disease caused by SAP-2 deficiency
8. Sphingolipid activator protein deficiency in a 16-week-old atypical Gaucher disease patient and his fetal sibling: Biochemical signs of combined sphingolipidosis
9. Additional biochemical findings in a patient and fetal sibling with a genetic defect in the sphingolipid activator protein (SAP) precursor, prosaposin. Evidence for a deficiency in SAP-1 and for a normal lysosomal neuraminidase
10. Identification of the neurotrophic factor sequence of prosaposin
11. Identification of prosaposin as a neurotrophic factor
12. Functional organization of saposin C. Definition of the neurotrophic and acid beta-glucosidase activation regions
13. Prosaposin facilitates sciatic nerve regeneration in vivo
14. Conformational and amino acid residue requirements for the saposin C neuritogenic effect
15. Developmental and tissue-specific expression of prosaposin mRNA in murine tissues
16. Immunocytochemical localization of sulfated glycoprotein-1 (SGP-1) and identification of its transcripts in epithelial cells of the extratesticular duct system of the rat
17. Biosynthesis and molecular cloning of sulfated glycoprotein 1 secreted by rat Sertoli cells: Sequence similarity with the 70-kilodalton precursor to sulfatide/GM1 activator
18. Wat1/Cip1/Sdi1 on cellular gene expression: Implications tor carcinogenesis, senescence, and age-related diseases
19. The mouse prosaposin locus: Promoter organization
20. The organization ot the gene tor the human cerebroside sulfate activator protein
21. Molecular cloning of a human cobeta-glucusidase cDNA: Evidence thai tour sphingolipid hydrolase activator proteins are encoded by single genes in human and rats
22. Targeted disruption of the mouse sphingolipid activator protein gene: A complex phenotype, including severe leukodystrophy and wide spread storage of multiple sphir golipids
23. Structural analysis of the mouse prosaposin (SGP-1) gene reveals the presence of an exon that is alternatively spliced in transcribed mRNAs
24. Role of Sp proteins and RORalpha in transcription regulation of murine prosaposin
25. Variegated gene expression in mice
26. Murine prosaposin: Expression in the reproductive system of a gene implicated in human genetic diseases
27. Isolation and characterization of the human prosaposin promoter
28. Neurological disturbances, premature lethality, and certraf myefination deficiency in transgenic mice overexpressing the homeo domain transcription factor Oct-6
29. Development and survival ot the endocrine hypothalamus and posterior pituitary gland requires the neuronal PDU domain factor Brn-2